Scandion Oncology A/S - SCOL.ST - Fundamentals

Best investment/trading ideas for the weekJoin our free webinar on April8,2026.

Combo Screeneris now available. Explore seasonality and pattern opportunities across asset classes.

Explore now

‌
‌

‌

Let's get started...

‌

Breakdown	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	TTM
REVENUE	0	0	0	0	0	0	0	--	📊
Revenue Growth (1Y)	--	--	--	-100.00%	--	--	--	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	-100.00%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	1	7	11	0	0	0	0	--	📊
Cost of Revenue Growth (1Y)	--	+430.80%	+53.91%	-100.00%	--	--	--	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	-100.00%	-100.00%	-100.00%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	-1	-7	-11	0	0	0	0	--	📊
Gross Profit Growth (1Y)	--	-430.80%	-51.13%	+100.00%	--	--	--	--	📊
Gross Profit Growth (5Y)	--	--	--	--	+100.00%	+100.00%	+100.00%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	0	3	15	23	55	80	45	41	📊
Operating Expenses Growth (1Y)	--	+592.16%	+503.98%	+48.63%	+141.90%	+44.79%	-43.42%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+14930.96%	+3044.29%	+194.55%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	0	3	11	14	3	7	14	22	📊
Research and Development	0	0	0	22	48	65	32	19	📊
Other Income Expenses	0	3	4	8	5	8	-0	--	📊
EBITDA	0	0	-16	-23	-56	-81	-46	-40	📊
EBITDA Growth (1Y)	--	--	--	-46.52%	-145.48%	-44.08%	+43.66%	--	📊
EBITDA Growth (5Y)	--	--	--	--	--	--	-191.93%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	2	10	-0	0	1	1	0	1	📊
Operating Income	-2	-10	-15	-23	-55	-80	-45	-41	📊
Operating Income Growth (1Y)	--	-464.62%	-54.93%	-48.70%	-141.90%	-44.79%	+43.42%	--	📊
Operating Income Growth (5Y)	--	--	--	--	-3046.73%	-706.94%	-194.69%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	1	0	0	1	📊
Pre Tax Income	-2	-10	-16	-21	-57	-82	-45	-41	📊
Tax Provision	0	-2	-3	-4	-6	-5	6	-4	📊
NET INCOME	-2	-8	-12	-16	-52	-77	-39	-37	📊
Net Income Growth (1Y)	--	-438.59%	-48.90%	-33.53%	-217.81%	-48.34%	+48.89%	--	📊
Net Income Growth (5Y)	--	--	--	--	-3303.32%	-837.36%	-221.78%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	-0.21	-0.8	-0.81	-0.51	-1.61	-1.79	-0.96	-0.29	📊
Diluted EPS	-0.21	-0.8	-0.81	-0.5	-1.54	-1.79	-0.96	-0.29	📊
Basic Average Shares	7	10	15	32	32	43	41	126	📊
Diluted Average Shares	7	10	15	32	34	43	41	126	📊

Breakdown

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

-100.00%

📊

Revenue Growth (5Y)

-100.00%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

+430.80%

+53.91%

-100.00%

📊

Cost of Revenue Growth (5Y)

-100.00%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-1

-7

-11

📊

Gross Profit Growth (1Y)

-430.80%

-51.13%

+100.00%

📊

Gross Profit Growth (5Y)

+100.00%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+592.16%

+503.98%

+48.63%

+141.90%

+44.79%

-43.42%

📊

Operating Expenses Growth (5Y)

+14930.96%

+3044.29%

+194.55%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-0

📊

EBITDA

-16

-23

-56

-81

-46

-40

📊

EBITDA Growth (1Y)

-46.52%

-145.48%

-44.08%

+43.66%

📊

EBITDA Growth (5Y)

-191.93%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

-0

📊

Operating Income

-2

-10

-15

-23

-55

-80

-45

-41

📊

Operating Income Growth (1Y)

-464.62%

-54.93%

-48.70%

-141.90%

-44.79%

+43.42%

📊

Operating Income Growth (5Y)

-3046.73%

-706.94%

-194.69%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-2

-10

-16

-21

-57

-82

-45

-41

📊

Tax Provision

-2

-3

-4

-6

-5

-4

📊

NET INCOME

-2

-8

-12

-16

-52

-77

-39

-37

📊

Net Income Growth (1Y)

-438.59%

-48.90%

-33.53%

-217.81%

-48.34%

+48.89%

📊

Net Income Growth (5Y)

-3303.32%

-837.36%

-221.78%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.21

-0.8

-0.81

-0.51

-1.61

-1.79

-0.96

-0.29

📊

Diluted EPS

-0.21

-0.8

-0.81

-0.5

-1.54

-1.79

-0.96

-0.29

📊

Basic Average Shares

126

📊

Diluted Average Shares

126

📊

Breakdown	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	TTM
REVENUE	0	0	0	0	0	0	0	--	📊
Revenue Growth (1Y)	--	--	--	-100.00%	--	--	--	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	-100.00%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	1	7	11	0	0	0	0	--	📊
Cost of Revenue Growth (1Y)	--	+430.80%	+53.91%	-100.00%	--	--	--	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	-100.00%	-100.00%	-100.00%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	-1	-7	-11	0	0	0	0	--	📊
Gross Profit Growth (1Y)	--	-430.80%	-51.13%	+100.00%	--	--	--	--	📊
Gross Profit Growth (5Y)	--	--	--	--	+100.00%	+100.00%	+100.00%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	0	3	15	23	55	80	45	41	📊
Operating Expenses Growth (1Y)	--	+592.16%	+503.98%	+48.63%	+141.90%	+44.79%	-43.42%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+14930.96%	+3044.29%	+194.55%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	0	3	11	14	3	7	14	22	📊
Research and Development	0	0	0	22	48	65	32	19	📊
Other Income Expenses	0	3	4	8	5	8	-0	--	📊
EBITDA	0	0	-16	-23	-56	-81	-46	-40	📊
EBITDA Growth (1Y)	--	--	--	-46.52%	-145.48%	-44.08%	+43.66%	--	📊
EBITDA Growth (5Y)	--	--	--	--	--	--	-191.93%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	2	10	-0	0	1	1	0	1	📊
Operating Income	-2	-10	-15	-23	-55	-80	-45	-41	📊
Operating Income Growth (1Y)	--	-464.62%	-54.93%	-48.70%	-141.90%	-44.79%	+43.42%	--	📊
Operating Income Growth (5Y)	--	--	--	--	-3046.73%	-706.94%	-194.69%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	1	0	0	1	📊
Pre Tax Income	-2	-10	-16	-21	-57	-82	-45	-41	📊
Tax Provision	0	-2	-3	-4	-6	-5	6	-4	📊
NET INCOME	-2	-8	-12	-16	-52	-77	-39	-37	📊
Net Income Growth (1Y)	--	-438.59%	-48.90%	-33.53%	-217.81%	-48.34%	+48.89%	--	📊
Net Income Growth (5Y)	--	--	--	--	-3303.32%	-837.36%	-221.78%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	-0.21	-0.8	-0.81	-0.51	-1.61	-1.79	-0.96	-0.29	📊
Diluted EPS	-0.21	-0.8	-0.81	-0.5	-1.54	-1.79	-0.96	-0.29	📊
Basic Average Shares	7	10	15	32	32	43	41	126	📊
Diluted Average Shares	7	10	15	32	34	43	41	126	📊

Breakdown

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

-100.00%

📊

Revenue Growth (5Y)

-100.00%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

+430.80%

+53.91%

-100.00%

📊

Cost of Revenue Growth (5Y)

-100.00%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-1

-7

-11

📊

Gross Profit Growth (1Y)

-430.80%

-51.13%

+100.00%

📊

Gross Profit Growth (5Y)

+100.00%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+592.16%

+503.98%

+48.63%

+141.90%

+44.79%

-43.42%

📊

Operating Expenses Growth (5Y)

+14930.96%

+3044.29%

+194.55%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-0

📊

EBITDA

-16

-23

-56

-81

-46

-40

📊

EBITDA Growth (1Y)

-46.52%

-145.48%

-44.08%

+43.66%

📊

EBITDA Growth (5Y)

-191.93%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

-0

📊

Operating Income

-2

-10

-15

-23

-55

-80

-45

-41

📊

Operating Income Growth (1Y)

-464.62%

-54.93%

-48.70%

-141.90%

-44.79%

+43.42%

📊

Operating Income Growth (5Y)

-3046.73%

-706.94%

-194.69%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-2

-10

-16

-21

-57

-82

-45

-41

📊

Tax Provision

-2

-3

-4

-6

-5

-4

📊

NET INCOME

-2

-8

-12

-16

-52

-77

-39

-37

📊

Net Income Growth (1Y)

-438.59%

-48.90%

-33.53%

-217.81%

-48.34%

+48.89%

📊

Net Income Growth (5Y)

-3303.32%

-837.36%

-221.78%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.21

-0.8

-0.81

-0.51

-1.61

-1.79

-0.96

-0.29

📊

Diluted EPS

-0.21

-0.8

-0.81

-0.5

-1.54

-1.79

-0.96

-0.29

📊

Basic Average Shares

126

📊

Diluted Average Shares

126

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	--
Next Earnings	--
Market cap	950.93K (SEK)
EPS (TTM)	-0.29 (SEK)
P/E (TTM)	-0.01 (SEK)
Last Close	0.00

Next Earnings	--
Market cap	950.93K (SEK)
EPS (TTM)	-0.29 (SEK)
P/E (TTM)	-0.01 (SEK)
Last Close	0.00 (SEK)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	--
Next Earnings	--
Market cap	950.93K (SEK)
EPS (TTM)	-0.29 (SEK)
P/E (TTM)	-0.01 (SEK)
Last Close	0.00

Next Earnings	--
Market cap	950.93K (SEK)
EPS (TTM)	-0.29 (SEK)
P/E (TTM)	-0.01 (SEK)
Last Close	0.00 (SEK)